[ad_1]
GE Healthcare’s stock dropped in early Wednesday trading, after the medical technologies and diagnostics company reported second-quarter revenue that missed expectations and free cash flow that turned more negative.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...